The Biggest Takeaway From ISRG Earnings [Forbes]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Forbes
the $2.50 EPS exceeding expectations and a revenue growth of 23%, this cycle reshapes the competitive environment for the upcoming decade. Strategic Displacement Of Competition The da Vinci 5 (dV5) made up 85% of system placements in the U.S. during Q1 2026. This swift uptake secures hospitals' capital budgets prior to Medtronic's (MDT) Hugo or Johnson & Johnson's (JNJ) Ottava establishing a meaningful presence in the U.S. While OUS (Outside the United States) markets encounter competition from clinical data from Hugo and domestic Chinese players such as MicroPort, ISRG's U.S. refresh secures high-acuity hospitals within its ecosystem for the lifespan of the system. This proactive approach to safeguarding long-term market share is reminiscent of the paths taken by other leaders in infrastructure. (See: AMD Stock Hits Record Highs – Is It Too Late To Buy? The Digital Compounding Of The Recurring Base Recurring revenue constituted 86% of the overall revenue mix, increasing by 23
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- IMAAVY® (nipocalimab)?shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG) [Yahoo! Finance]Yahoo! Finance
- Is Johnson & Johnson (JNJ) the Best Counter Cyclical Stock to Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- BNO Strengthens Leadership Team for Next Phase of Growth and Innovation [Yahoo! Finance]Yahoo! Finance
- US to speed up payments for new medical devices under Medicare, FT reports [Yahoo! Finance]Yahoo! Finance
- Is Johnson & Johnson (JNJ) a Buy on Sales Growth and Solid 2026 Guidance? [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/22/26 - Form 10-Q
- 4/14/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- JNJ's page on the SEC website